Maravai Lifesciences Holdings (MRVI) Retained Earnings (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Retained Earnings of $6.4 million in Q1 2026, up 1118.51% quarter-over-quarter from $524000.0 in Q4 2025, and up 1870.68% on a YoY basis from $324000.0 in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Retained Earnings (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Retained Earnings history runs 7 years deep, the most recent figure standing at $6.4 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 1870.68% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $6.4 million (up 1870.68% YoY), while the FY2025 annual figure was $524000.0, changed N/A from the prior year.
- Retained Earnings was $6.4 million for Q1 2026 at Maravai Lifesciences Holdings, up from $524000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $404.8 million in Q4 2022 to a low of $324000.0 in Q1 2025.
- Historically, Retained Earnings has averaged $228.4 million across 5 years, with a median of $268.8 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Retained Earnings tumbled 99.88% in 2025, then soared 1870.68% in 2026.
- A 5-year view of Retained Earnings shows it stood at $404.8 million in 2022, then dropped by 29.41% to $285.7 million in 2023, then plunged by 41.63% to $166.8 million in 2024, then plunged by 99.69% to $524000.0 in 2025, then soared by 1118.51% to $6.4 million in 2026.
- The last three Retained Earnings figures came in at $6.4 million (Q1 2026), $524000.0 (Q4 2025), and $45.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -838.07 Mn |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn | 6.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.39 Mn |
| Dec 31, 2025 | 524,000.00 |
| Sep 30, 2025 | 45.80 Mn |
| Jun 30, 2025 | 71.36 Mn |
| Mar 31, 2025 | 324,000.00 |
| Sep 30, 2024 | 166.80 Mn |
| Jun 30, 2024 | 263.87 Mn |
| Mar 31, 2024 | 273.66 Mn |
| Dec 31, 2023 | 285.74 Mn |
| Sep 30, 2023 | 391.70 Mn |
| Jun 30, 2023 | 398.16 Mn |
| Mar 31, 2023 | 404.70 Mn |
| Dec 31, 2022 | 404.77 Mn |
| Sep 30, 2022 | 367.13 Mn |
| Jun 30, 2022 | 322.66 Mn |
| Mar 31, 2022 | 251.42 Mn |
| Dec 31, 2021 | 184.56 Mn |
| Sep 30, 2021 | 128.73 Mn |
| Jun 30, 2021 | 74.77 Mn |
| Mar 31, 2021 | 25.63 Mn |